EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis

Chase J Wehrle iD, Jenny H Chang, Abby R Gross, Kimberly Woo, Robert Naples, Kathryn A Stackhouse, Fadi Dahdaleh, Toms Augustin, Daniel Joyce, Robert Simon, R Matthew Walsh, Samer A Naffouje

Surgical Endoscopy · 2024

DOI: 10.1007/s00464-024-10783-1 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Surgical Endoscopy, 2024. Verfasst von Chase J Wehrle und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. wehrlec@ccf.org. Hauptthemen laut MEDLINE: Pancreaticoduodenectomy, Robotic Surgical Procedures, Pancreatic Neoplasms, Propensity Score. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Minimally invasive Pancreatoduodenectomy (MIPD), or the Whipple procedure, is increasingly utilized. No study has compared laparoscopic (LPD) and robotic (RPD) approaches, and the impact of the learning curve on oncologic, technical, and post-operative outcomes remains relatively understudied.

Methods

The National Cancer Database was queried for patients undergoing LPD or RPD from 2010 to 2020 with a diagnosis of pancreatic cancer. Outcomes were compared between approaches using propensity-score matching (PSM); the impact of annual center-level volume of MIPD was also assessed by dividing volume into quartiles.

Results

A total of 3,342 patients were included. Most ( n = 2,716, 81.3%) underwent LPD versus RPD ( n = 626, 18.7%). There was a high rate (20.2%, n = 719) of positive margins. Mean length-of-stay (LOS) was 10.4 ± 8.9 days. Thirty-day mortality was 2.8% ( n = 92) and ninety-day mortality was 5.7% ( n = 189). PSM matched 625 pairs of patients receiving LPD or RPD. After PSM, there was no differences between groups based on age, sex, race, CCI, T-stage, neoadjuvant chemo/radiotherapy, or type of PD. After PSM, there was a higher rate of conversion to open (HR = 0.68, 95%CI = 0.50–0.92)., but there was no difference in LOS (HR = 1.00, 95%CI = 0.92–1.11), 30-day readmission (HR = 1.08, 95% CI = 0.68–1.71), 30-day (HR = 0.78, 95% CI = 0.39–1.56) or 90-day mortality (HR = 0.70, 95% CI = 0.42–1.16), ability to receive adjuvant therapy (HR = 1.15, 95% CI = 0.92–1.44), nodal harvest (HR = 1.01, 95%CI = 0.94–1.09) or positive margins (HR = 1.19, 95% CI = 0.89–1.59). Centers in lower quartiles of annual volume of MIPD demonstrated reduced nodal harvest ( p = 0.005) and a higher rate of conversion to open ( p = 0.038). Higher-volume centers had a shorter LOS ( p = 0.012), higher rate of initiation of adjuvant therapy ( p = 0.042), and, most strikingly, a reduction in 90-day mortality ( p = 0.033).

Conclusion

LPD and RPD have similar surgical and oncologic outcomes, with a lower rate of conversion to open in the robotic cohort. The robotic technique does not appear to eliminate the “learning curve”, with higher volume centers demonstrating improved outcomes, especially seen at minimum annual volume of 5 cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreaticoduodenectomyRobotic Surgical ProceduresPancreatic NeoplasmsPropensity ScoreLaparoscopyHumansMaleFemaleAgedMiddle AgedTreatment OutcomeLength of StayPostoperative ComplicationsRetrospective StudiesMargins of ExcisionLearning Curve

Stichwörter der Autor:innen

Laparoscopic surgeryMinimally invasive surgeryPancreatic ductal adenocarcinomaPancreatoduodenectomyRobotic surgery

Autor:innen und Institutionen

  • Department of General Surgery, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. wehrlec@ccf.org.
  • Department of General Surgery, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA.
  • Department of Surgical Oncology, Edward-Elmhurst Health, Naperville, IL, USA.

ORCID-Profile: Chase J Wehrle

Zitieren

APA

Wehrle, C. J., Chang, J. H., Gross, A. R., Woo, K., Naples, R., Stackhouse, K. A., Dahdaleh, F., Augustin, T., Joyce, D., Simon, R., Walsh, R. M., & Naffouje, S. A. (2024). Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-10783-1

Vancouver

Wehrle CJ, Chang JH, Gross AR, Woo K, Naples R, Stackhouse KA, et al. Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis. Surgical Endoscopy. 2024. doi:10.1007/s00464-024-10783-1

BibTeX
@article{Wehrle2024,
  author = {Wehrle, Chase J and Chang, Jenny H and Gross, Abby R and Woo, Kimberly and Naples, Robert and Stackhouse, Kathryn A and Dahdaleh, Fadi and Augustin, Toms and Joyce, Daniel and Simon, Robert and Walsh, R Matthew and Naffouje, Samer A},
  title = {Comparing oncologic and surgical outcomes of robotic and laparoscopic pancreatoduodenectomy in patients with pancreatic cancer: a propensity-matched analysis},
  journal = {Surgical Endoscopy},
  year = {2024},
  doi = {10.1007/s00464-024-10783-1}
}
Kostenlos starten →